Ramsay Générale de Santé SA (GDS.PA)
EUR 11.5
(0.44%)
EUR 11.5
(0.44%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -53.9 Million EUR | -209.11% |
| 2022 | 49.4 Million EUR | -58.28% |
| 2021 | 118.4 Million EUR | 82.15% |
| 2020 | 65 Million EUR | 247.59% |
| 2019 | 18.7 Million EUR | 22.22% |
| 2018 | 15.3 Million EUR | 109.59% |
| 2017 | 7.3 Million EUR | -87.19% |
| 2016 | 57 Million EUR | 54.47% |
| 2015 | 36.9 Million EUR | 87.31% |
| 2014 | 19.7 Million EUR | -82.3% |
| 2013 | 111.3 Million EUR | 99.82% |
| 2012 | 55.7 Million EUR | 295.44% |
| 2011 | -28.5 Million EUR | -175.2% |
| 2010 | 37.9 Million EUR | -10.61% |
| 2009 | 42.4 Million EUR | -51.38% |
| 2008 | 87.2 Million EUR | 91.23% |
| 2007 | 45.6 Million EUR | -79.77% |
| 2006 | 225.4 Million EUR | 451.1% |
| 2005 | 40.9 Million EUR | 49.27% |
| 2004 | 27.4 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -8.65 Million EUR | -257.27% |
| 2023 Q3 | -3.3 Million EUR | 80.92% |
| 2023 FY | -53.9 Million EUR | -209.11% |
| 2023 Q4 | -33.29 Million EUR | -909.09% |
| 2023 Q2 | -17.3 Million EUR | -100.0% |
| 2022 Q2 | 43.9 Million EUR | 100.0% |
| 2022 FY | 49.4 Million EUR | -58.28% |
| 2022 Q4 | 5.5 Million EUR | 100.0% |
| 2022 Q3 | 2.75 Million EUR | -93.74% |
| 2022 Q1 | 21.95 Million EUR | -62.73% |
| 2021 Q4 | 58.9 Million EUR | 100.34% |
| 2021 FY | 118.4 Million EUR | 82.15% |
| 2021 Q1 | 29.8 Million EUR | 68.36% |
| 2021 Q2 | 59.6 Million EUR | 100.0% |
| 2021 Q3 | 29.4 Million EUR | -50.67% |
| 2020 Q4 | 17.7 Million EUR | 100.0% |
| 2020 FY | 65 Million EUR | 247.59% |
| 2020 Q3 | 8.85 Million EUR | -81.29% |
| 2020 Q2 | 47.3 Million EUR | 100.0% |
| 2020 Q1 | 23.65 Million EUR | 76.49% |
| 2019 Q1 | 600 Thousand EUR | -92.68% |
| 2019 Q2 | 1.2 Million EUR | 100.0% |
| 2019 Q3 | 6.7 Million EUR | 458.33% |
| 2019 Q4 | 13.4 Million EUR | 100.0% |
| 2019 FY | 18.7 Million EUR | 22.22% |
| 2018 FY | 15.3 Million EUR | 109.59% |
| 2018 Q4 | 8.19 Million EUR | 100.0% |
| 2018 Q3 | 4.09 Million EUR | 720.0% |
| 2018 Q2 | 500 Thousand EUR | 0.0% |
| 2018 Q1 | 500 Thousand EUR | -96.6% |
| 2017 Q4 | 14.7 Million EUR | 0.0% |
| 2017 Q3 | 14.7 Million EUR | 233.03% |
| 2017 Q1 | -11.05 Million EUR | -168.42% |
| 2017 Q2 | -11.05 Million EUR | 0.0% |
| 2017 FY | 7.3 Million EUR | -87.19% |
| 2016 Q3 | 16.14 Million EUR | 30.77% |
| 2016 Q2 | 12.35 Million EUR | 0.0% |
| 2016 FY | 57 Million EUR | 54.47% |
| 2016 Q1 | 12.35 Million EUR | 9.29% |
| 2016 Q4 | 16.14 Million EUR | 0.0% |
| 2015 Q1 | 7.25 Million EUR | 0.0% |
| 2015 FY | 36.9 Million EUR | 87.31% |
| 2015 Q2 | 7.25 Million EUR | 0.0% |
| 2015 Q3 | 11.3 Million EUR | 55.86% |
| 2015 Q4 | 11.3 Million EUR | 0.0% |
| 2014 FY | 19.7 Million EUR | -82.3% |
| 2014 Q2 | -7.7 Million EUR | -7800.0% |
| 2014 Q1 | 100 Thousand EUR | -97.83% |
| 2013 Q3 | 22.8 Million EUR | -87.61% |
| 2013 Q1 | 700 Thousand EUR | -90.67% |
| 2013 Q2 | 184 Million EUR | 26185.71% |
| 2013 FY | 111.3 Million EUR | 99.82% |
| 2013 Q4 | 4.6 Million EUR | -79.82% |
| 2012 FY | 55.7 Million EUR | 295.44% |
| 2012 Q4 | 7.5 Million EUR | -61.14% |
| 2012 Q3 | 19.3 Million EUR | 49.61% |
| 2012 Q2 | 12.9 Million EUR | -12.24% |
| 2012 Q1 | 14.7 Million EUR | 67.05% |
| 2011 Q3 | 19.3 Million EUR | 160.12% |
| 2011 Q4 | 8.8 Million EUR | -54.4% |
| 2011 Q2 | -32.1 Million EUR | -143.18% |
| 2011 FY | -28.5 Million EUR | -175.2% |
| 2011 Q1 | -13.2 Million EUR | 54.79% |
| 2010 FY | 37.9 Million EUR | -10.61% |
| 2010 Q1 | -17.4 Million EUR | -131.75% |
| 2010 Q2 | -9.9 Million EUR | 43.1% |
| 2010 Q3 | 7.5 Million EUR | 175.76% |
| 2010 Q4 | -29.2 Million EUR | -489.33% |
| 2009 Q2 | 28.5 Million EUR | 0.0% |
| 2009 FY | 42.4 Million EUR | -51.38% |
| 2009 Q4 | 54.8 Million EUR | 630.67% |
| 2009 Q3 | 7.5 Million EUR | -73.68% |
| 2008 FY | 87.2 Million EUR | 91.23% |
| 2007 FY | 45.6 Million EUR | -79.77% |
| 2006 FY | 225.4 Million EUR | 451.1% |
| 2005 FY | 40.9 Million EUR | 49.27% |
| 2004 FY | 27.4 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Clariane SE | -105.24 Million EUR | 48.786% |
| LNA Santé SA | 23.4 Million EUR | 330.253% |